Authors: Climo, MW Ehlert, K Archer, GL

Citation: Mw. Climo et al., Mechanism and suppression of lysostaphin resistance in oxacillin-resistantStaphylococcus aureus, ANTIM AG CH, 45(5), 2001, pp. 1431-1437

Authors: Finan, JE Archer, GL Pucci, MJ Climo, MW

Citation: Je. Finan et al., Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus, ANTIM AG CH, 45(11), 2001, pp. 3070-3075

Authors: Archer, GL Climo, MW

Citation: Gl. Archer et Mw. Climo, Staphylococcus aureus bacteremia - Consider the source., N ENG J MED, 344(1), 2001, pp. 55-56

Authors: Franchi, D Climo, MW Wong, AHM Edmond, MB Wenzel, RP

Citation: D. Franchi et al., Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci, CLIN INF D, 29(6), 1999, pp. 1566-1568

Authors: Climo, MW Patron, RL Archer, GL

Citation: Mw. Climo et al., Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin, ANTIM AG CH, 43(7), 1999, pp. 1747-1753

Authors: Patron, RL Climo, MW Goldstein, BP Archer, GL

Citation: Rl. Patron et al., Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin, ANTIM AG CH, 43(7), 1999, pp. 1754-1755